Skip to Content

Nexium IV Approved for Gastroesophageal Reflux Disease (GERD)

Nexium IV (esomeprazole sodium) is a new administration formulation for the prescription proton pump inhibitor Nexium. Nexium IV is approved as an intravenous infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease (GERD) patients, with a history of erosive esophagitis, who are unable to take capsules.

Posted: March 2005

Related Articles: